Jyothy Labs Q4 FY26 Earnings Call Transcript Released
Jyothy Labs released its Q4 FY26 earnings call transcript. For FY26, revenue grew 3.5% to ₹2,944 crore, with EBITDA margin at 15.3%. Q4 FY26 revenue was ₹717 crore, up 7.7%. The company has a strong cash balance of ₹1,000 crore and recommended a final dividend of ₹3.5 per share. Management noted margin pressures due to input costs but remains cautiously optimistic for FY27.
The announcement provides detailed financial performance for the quarter and year, along with management's outlook and responses to investor queries. This information is material for investors and analysts, impacting investment decisions.
The announcement is a transcript of an earnings call discussing financial results and outlook. While the results show growth, there are also challenges mentioned regarding input cost inflation and market volatility, leading to a neutral sentiment.
Jyothy Labs Limited has released the transcript of its earnings conference call held on May 4, 2026. The call focused on the Audited Financial Results for the quarter and year ended March 31, 2026, and the company's future outlook.
During the discussion, management highlighted that FY26 was a year of volatility for the FMCG sector, with uneven urban demand and elevated input costs. Despite these challenges, the company maintained steady volume growth, supported by calibrated grammage actions and gradual demand improvement, especially in the second half of the fiscal year. Rural markets remained relatively resilient. The company reported a full-year revenue growth of 3.5% in value and 6% in volumes. Fabric Care saw strong growth, with liquids doubling during the year. Dishwash experienced a value decline despite volume growth due to competition and price cuts. Personal Care, particularly the Margo franchise, showed recovery, with expectations of a stronger FY27.
For Q4 FY26, revenue stood at ₹717 crores, an increase of 7.7% year-on-year. Gross margin was 45.2%, and EBITDA margin was 13.5%. For the full year 2026, revenue was ₹2,944 crores (up 3.5%), with an EBITDA margin of 15.3%. The company reported a Profit After Tax (PAT) of ₹333 crores and maintained a debt-free status with a cash balance of ₹1,000 crores. The Board recommended a final dividend of ₹3.5 per share for FY26.
Management acknowledged input cost pressures, particularly from crude oil price increases and currency movements, which are expected to impact margins in the near term. Selective price increases were implemented in March, with further actions contingent on input cost movements. The company expressed caution about FY27 due to the uncertain external environment but remains focused on scaling new product developments, improving general trade productivity, and sustaining volume growth.
What to do with a filing like this
Jyothy Labs Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jyothy Labs Limited. Read the original for the full detail.